JURKAT_Control_vs_JURKAT_Treatment

JURKAT_Control vs JURKAT_Treatment

p-value ≤ 0.05 0 significant 2025-09-26 00:00:00 Study: MTBLS789
77 Total Features
0 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS789_0001_00000001
Linked study
MTBLS789 — Metabolic effects of an aspartate aminotransferase-inhibitor on two T-cell lines
Comparison
JURKAT_Control vs JURKAT_Treatment
Group A
Control group of JURKAT E-6.1 cells. Provides baseline data for comparison with treated JURKAT E-6.1 cells
Group B
Treated group of JURKAT E-6.1 cells with hydrazinosuccinic acid. Allows assessment of the effects of hydrazinosuccinic acid on JURKAT E-6.1 cells
Total features tested
77
Significant features
0
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value